Medicare Enrolled
Dr. Viral Mehta, MD
Cardiovascular Disease · Bakersfield, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mehta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mehta?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mehta
Dr. Viral Mehta is a cardiovascular disease specialist in Bakersfield, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mehta performed 5,125 Medicare services across 1,996 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mehta received a total of $3,973 from 36 pharmaceutical and/or device companies across 148 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mehta is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 19% volume in CA
$3,973 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,125
Medicare services
Top 19% in CA for cardiovascular disease
1,996
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~256 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,192 | $94 | $285 |
| Injection, atropine sulfate, 0.01 mg | 1,040 | $0 | $2 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
555 | $49 | $130 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
388 | $11 | $80 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
231 | $40 | $160 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
226 | $42 | $192 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
167 | $18 | $120 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
167 | $20 | $80 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
167 | $52 | $90 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
102 | $123 | $555 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
97 | $22 | $115 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
85 | $156 | $1,200 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
73 | $28 | $205 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
67 | $160 | $575 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
56 | $201 | $455 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
55 | $88 | $375 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
55 | $70 | $195 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
54 | $161 | $645 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
40 | $62 | $210 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
40 | $188 | $855 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
37 | $726 | $2,825 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages. |
30 | $104 | $400 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
29 | $20 | $100 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
24 | $44 | $270 |
| Injection, dobutamine hydrochloride, per 250 mg | 24 | $6 | $25 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
22 | $137 | $385 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
19 | $143 | $525 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
19 | $65 | $195 |
| Cardiac catheterization | 18 | $206 | $945 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
18 | $33 | $120 |
| Evaluation of implantable heart and blood vessel monitoring system This procedure involves checking the function and data of an implanted device used to monitor heart and blood vessel activity. |
16 | $34 | $100 |
| Radiofrequency vein destruction, first vein A procedure to treat the first incompetent vein in the arm or leg using radiofrequency energy and imaging guidance. |
12 | $933 | $5,000 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.8% high complexity
26.7% medium
63.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,973
Total received (2018-2024)
Avg $568/year across 7 years
Top 46% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
148
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,894 (98.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$78 (2.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$308
2023
$686
2022
$266
2021
$488
2020
$195
2019
$605
2018
$1,424
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme LLC
$44
PFIZER INC.
$40
Impulse Dynamics (USA) Inc.
$39
Daiichi Sankyo Inc.
$27
Boston Scientific Corporation
$25
ShockWave Medical, Inc
$24
AltaThera Pharmaceuticals LLC
$23
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$22
Kiniksa Pharmaceuticals International, plc
$19
Penumbra, Inc.
$16
Novartis Pharmaceuticals Corporation
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Top 3 companies account for 40.1% of 2024 payments
All-time payments by company (2018-2024) ›
ABIOMED
$722
Edwards Lifesciences Corporation
$575
Boston Scientific Corporation
$259
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$237
Amgen Inc.
$230
Novartis Pharmaceuticals Corporation
$212
iRhythm Technologies, Inc.
$176
Medtronic Vascular, Inc.
$173
Abbott Laboratories
$157
PFIZER INC.
$155
BOSTON SCIENTIFIC CORPORATION
$129
Gilead Sciences, Inc.
$84
Novo Nordisk Inc
$78
Boehringer Ingelheim Pharmaceuticals, Inc.
$78
AstraZeneca Pharmaceuticals LP
$78
AngioDynamics, Inc.
$77
Janssen Pharmaceuticals, Inc
$58
SANOFI-AVENTIS U.S. LLC
$44
Merck Sharp & Dohme LLC
$44
ATRICURE, INC.
$39
Impulse Dynamics (USA) Inc.
$39
Kowa Pharmaceuticals America, Inc.
$36
Akcea Therapeutics, Inc.
$35
Regeneron Healthcare Solutions, Inc.
$31
Daiichi Sankyo Inc.
$27
Astellas Pharma US Inc
$25
ShockWave Medical, Inc
$24
AltaThera Pharmaceuticals LLC
$23
Kiniksa Pharmaceuticals International, plc
$19
Lundbeck LLC
$18
Cardiovascular Systems Inc.
$16
Penumbra, Inc.
$16
E.R. Squibb & Sons, L.L.C.
$15
GlaxoSmithKline, LLC.
$15
ACIST MEDICAL SYSTEMS, INC.
$14
Lexicon Pharmaceuticals, Inc.
$14
Top 3 companies account for 39.2% of all-time payments
Associated products mentioned in payments ›
ALPHAVAC · AMPLATZER AMULET · AREXVY · Arcalyst · BRILINTA · CHANTIX · CVI CONSUMABLES · CareLink · ClosureFast · CoreValve Evolut · Corlanor · ELIQUIS · ENTRESTO · Edwards SAPIEN 3 Transcatheter Heart Valve · FARXIGA · GARDASIL · GENERAL STENTS · General - Therapies · INJECTAFER · Impella · Indigo System · Inpefa · JARDIANCE · LATITUDE · LEQVIO · LEXISCAN · LUX DX · Legacy · LifeVest · Livalo · NORTHERA · Optimizer · PERCLOSE PROGLIDE · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · Repatha · SYNERGY · SYNERGY ABLATION SYSTEM · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Sotalol Hydrochloride · TEGSEDI · VYNDAQEL · Varithena Administration Pack · ViewMate Intracardiac Echo · XARELTO · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
30
Per 100K population
3.3
County median income
$67,660
Nearest hospital
BAKERSFIELD BEHAVIORAL HEALTHCARE HOSPITAL, LLC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mehta is a clinical cardiology specialist, with above-average Medicare volume (top 19% in CA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mehta experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mehta performed 1,192 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mehta receive payments from pharmaceutical companies?
Yes. Dr. Mehta received a total of $3,973 from 36 companies across 148 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mehta's costs compare to other cardiologists in Bakersfield?
Dr. Mehta's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mehta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Bakersfield
Browse cardiologists in Bakersfield ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
ABIOMED Payments to Doctors
See all physicians who received payments from ABIOMED.
By company
Edwards Lifesciences Corporation Payments to Doctors
See all physicians who received payments from Edwards Lifesciences Corporation.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology